Bio-Rad Laboratories Inc (BIO)
279.83
+0.52
(+0.19%)
USD |
NYSE |
May 03, 16:00
280.08
+0.25
(+0.09%)
Pre-Market: 20:00
Bio-Rad Laboratories Cash from Financing (TTM): -425.65M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -425.65M |
| September 30, 2023 | -311.65M |
| June 30, 2023 | -293.82M |
| March 31, 2023 | -212.41M |
| December 31, 2022 | 973.58M |
| September 30, 2022 | 1.065B |
| June 30, 2022 | 1.058B |
| March 31, 2022 | 1.182B |
| December 31, 2021 | -55.43M |
| September 30, 2021 | -481.95M |
| June 30, 2021 | -465.93M |
| March 31, 2021 | -471.77M |
| December 31, 2020 | -523.04M |
| September 30, 2020 | -105.94M |
| June 30, 2020 | -110.87M |
| March 31, 2020 | -123.54M |
| December 31, 2019 | -22.76M |
| September 30, 2019 | -64.98M |
| June 30, 2019 | -62.66M |
| March 31, 2019 | -49.03M |
| December 31, 2018 | -48.68M |
| September 30, 2018 | 1.899M |
| June 30, 2018 | 1.235M |
| March 31, 2018 | 2.183M |
| December 31, 2017 | 0.341M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.406M |
| June 30, 2017 | 5.331M |
| March 31, 2017 | 9.435M |
| December 31, 2016 | 9.02M |
| September 30, 2016 | 9.919M |
| June 30, 2016 | 9.145M |
| March 31, 2016 | 9.17M |
| December 31, 2015 | 8.581M |
| September 30, 2015 | 8.478M |
| June 30, 2015 | 8.121M |
| March 31, 2015 | 7.868M |
| December 31, 2014 | 11.69M |
| September 30, 2014 | 11.83M |
| June 30, 2014 | -299.26M |
| March 31, 2014 | -300.78M |
| December 31, 2013 | -311.70M |
| September 30, 2013 | -311.95M |
| June 30, 2013 | -0.067M |
| March 31, 2013 | 1.443M |
| December 31, 2012 | 12.59M |
| September 30, 2012 | 7.34M |
| June 30, 2012 | 6.842M |
| March 31, 2012 | 4.902M |
| December 31, 2011 | -213.56M |
| September 30, 2011 | 9.695M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-523.04M
Minimum
Dec 2020
1.182B
Maximum
Mar 2022
28.75M
Average
-110.87M
Median
Jun 2020
Cash from Financing (TTM) Benchmarks
| Agilent Technologies Inc | -1.153B |
| Bruker Corp | -11.00M |
| Azenta Inc | -452.51M |
| Harvard Bioscience Inc | -12.13M |
| Bionano Genomics Inc | 113.82M |